Kathleen G Phelan from Hinsdale, IL, age 46

Medicine Doctors

Kathleen M. Phelan

view source

Specialties:

Family Medicine

Work:

ProHealth Care Medical AssociatesProhealth Care Medical Group
1500 Walnut Rdg Dr, Hartland, WI 53029
(262)5137500 (phone), (262)3678744 (fax)

Education:

Medical School
University of Iowa Carver College of Medicine
Graduated: 1994

Conditions:

Abnormal Vaginal Bleeding
Acne
Acute Bronchitis
Acute Pharyngitis
Acute Sinusitis

Languages:

English

Description:

Dr. Phelan graduated from the University of Iowa Carver College of Medicine in 1994. She works in Hartland, WI and specializes in Family Medicine. Dr. Phelan is affiliated with Oconomowoc Memorial Hospital and Waukesha Memorial Hospital.

Resumes

Kathleen Phelan

view source

Kathleen Phelan

view source

Kathleen Phelan

view source

Kathleen Phelan

view source

Kathleen Phelan

view source

Kathleen Phelan

view source

Kathleen Phelan

view source

Kathleen Phelan

view source

Location:

United States

License Records

Kathleen R Phelan

License #:

PT2284 - Expired

Category:

PHYSICAL THERAPY

Issued Date:

Jan 1, 1901

Expiration Date:

Jan 31, 2001

Type:

PHYSICAL THERAPIST

Us Patents

Cyclic And Bicyclic Diamino Histamine-3 Receptor Antagonists
view source
US Patent:

20010049367, Dec 6, 2001
Filed:

Mar 5, 2001
Appl. No.:

09/799450
Inventors:

Youssef Bennani - Lake Bluff IL, US
Lawrence Black - Libertyville IL, US
Wesley Dwight - San Diego IL, US
Ramin Faghih - Lake Forest IL, US
Robert Gentles - Libertyville IL, US
Huaqing Liu - Buffalo Grove IL, US
Kathleen Phelan - Gurnee IL, US
Anil Vasudevan - Gurnee IL, US
Henry Zhang - Grayslake IL, US
International Classification:

A61K031/55
A61K031/551
A61K031/541
A61K031/5355
US Classification:

514/214030, 514/210200, 514/210210, 514/218000, 514/227800, 514/235800, 514/252120, 514/252140, 514/253010, 514/217030, 514/217040, 514/300000, 514/151000
Abstract:

Compounds of formula (I) compounds of formula (II) compounds of formula (III) and compounds of formula (IV) or pharmaceutically acceptable salts thereof are useful as Hreceptor antagonists. Processes to make the compounds and methods of treatment using the compounds are also disclosed.